Watchlist Manager

Watchlist

Price: 5.01 CNY 1.01% Market Closed

Market Cap: ¥25.3B

	Jointown Pharmaceutical Group Co Ltd SSE:600998	CN

Income Statement

Currency: CNY

	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	134	0	0	0	184	0	0	0	299	0	0	0	373	0	0	0	413	0	0	0	546	0	0	0	671	0	0	169	716	0	0	0	889	545	858	1 187	1 240	1 264	1 180	1 099	1 027	1 029	975	984	1 145	1 130	1 235	1 307	1 221	1 258	1 313	1 337	1 318	1 292	1 291	1 267	1 284	1 218	0	0
Revenue	21 185 N/A	22 008 +4%	22 934 +4%	23 867 +4%	24 839 +4%	26 318 +6%	27 383 +4%	28 510 +4%	29 508 +4%	30 077 +2%	31 096 +3%	32 098 +3%	33 438 +4%	35 150 +5%	37 188 +6%	39 272 +6%	41 068 +5%	43 171 +5%	45 050 +4%	46 895 +4%	49 589 +6%	53 090 +7%	55 481 +5%	58 367 +5%	61 557 +5%	64 925 +5%	67 999 +5%	70 782 +4%	73 943 +4%	77 338 +5%	80 163 +4%	83 230 +4%	87 136 +5%	89 589 +3%	93 116 +4%	96 769 +4%	99 497 +3%	102 007 +3%	102 417 +0%	106 437 +4%	110 860 +4%	116 315 +5%	121 491 +4%	122 634 +1%	122 407 0%	124 929 +2%	128 411 +3%	133 260 +4%	140 424 +5%	147 366 +5%	151 797 +3%	151 842 +0%	150 140 -1%	148 519 -1%	147 953 0%	149 205 +1%	151 810 +2%	153 354 +1%	155 745 +2%	157 707 +1%
Gross Profit
Cost of Revenue	(19 822)	(20 586)	(21 490)	(22 376)	(23 375)	(24 784)	(25 759)	(26 812)	(27 636)	(28 169)	(29 122)	(30 037)	(31 215)	(32 847)	(34 705)	(36 583)	(38 159)	(40 089)	(41 776)	(43 474)	(45 848)	(49 210)	(51 354)	(54 025)	(56 737)	(59 928)	(62 627)	(64 978)	(67 712)	(70 974)	(73 616)	(76 466)	(79 628)	(82 087)	(85 194)	(88 638)	(90 809)	(93 252)	(93 087)	(96 703)	(100 952)	(106 304)	(111 552)	(112 727)	(112 605)	(115 420)	(118 667)	(123 287)	(129 523)	(136 137)	(139 995)	(140 055)	(138 099)	(137 110)	(136 851)	(137 779)	(140 025)	(141 767)	(144 291)	(146 056)
Gross Profit	1 363 N/A	1 423 +4%	1 444 +1%	1 490 +3%	1 464 -2%	1 532 +5%	1 622 +6%	1 696 +5%	1 871 +10%	1 907 +2%	1 973 +3%	2 060 +4%	2 224 +8%	2 302 +4%	2 483 +8%	2 689 +8%	2 909 +8%	3 081 +6%	3 272 +6%	3 419 +4%	3 741 +9%	3 879 +4%	4 127 +6%	4 342 +5%	4 820 +11%	4 998 +4%	5 373 +8%	5 806 +8%	6 230 +7%	6 366 +2%	6 548 +3%	6 764 +3%	7 509 +11%	7 501 0%	7 922 +6%	8 130 +3%	8 689 +7%	8 754 +1%	9 329 +7%	9 734 +4%	9 907 +2%	10 011 +1%	9 939 -1%	9 907 0%	9 802 -1%	9 509 -3%	9 744 +2%	9 974 +2%	10 901 +9%	11 229 +3%	11 802 +5%	11 787 0%	12 041 +2%	11 410 -5%	11 102 -3%	11 425 +3%	11 785 +3%	11 587 -2%	11 454 -1%	11 651 +2%
Operating Income
Operating Expenses	(792)	(841)	(860)	(890)	(939)	(963)	(1 019)	(1 085)	(1 191)	(1 211)	(1 264)	(1 304)	(1 418)	(1 463)	(1 589)	(1 754)	(1 930)	(2 038)	(2 124)	(2 213)	(2 445)	(2 525)	(2 669)	(2 805)	(3 150)	(3 228)	(3 432)	(3 809)	(4 133)	(4 139)	(4 327)	(4 403)	(4 950)	(4 686)	(4 846)	(4 957)	(5 381)	(5 192)	(5 295)	(5 527)	(6 125)	(5 986)	(6 165)	(6 170)	(6 611)	(6 367)	(6 407)	(6 569)	(7 350)	(7 518)	(7 908)	(7 877)	(7 879)	(7 279)	(7 133)	(7 404)	(7 787)	(7 677)	(7 963)	(8 126)
Selling, General & Administrative	(787)	(830)	(853)	(882)	(934)	(953)	(1 004)	(1 067)	(1 031)	(1 194)	(1 239)	(1 279)	(1 235)	(1 431)	(1 560)	(1 690)	(1 708)	(1 994)	(2 058)	(2 179)	(2 167)	(2 450)	(2 618)	(2 761)	(2 824)	(3 074)	(3 292)	(3 634)	(3 736)	(4 142)	(4 318)	(4 404)	(4 498)	(4 775)	(4 934)	(5 078)	(4 961)	(5 241)	(5 411)	(5 652)	(5 640)	(6 113)	(6 233)	(6 214)	(6 069)	(6 326)	(6 384)	(6 571)	(6 772)	(7 466)	(7 863)	(7 819)	(7 341)	(7 308)	(7 147)	(7 402)	(7 198)	(7 647)	(7 885)	(8 064)
Research & Development	0	0	0	0	0	0	0	0	(15)	0	0	0	(12)	0	0	0	(12)	0	0	0	(12)	0	0	0	(11)	0	0	(18)	(71)	0	0	(46)	(74)	(64)	(79)	(75)	(71)	(72)	(82)	(86)	(120)	(139)	(150)	(179)	(181)	(210)	(215)	(203)	(163)	(176)	(184)	(190)	(175)	(202)	(176)	(163)	(133)	(139)	(147)	(146)
Depreciation & Amortization	0	0	0	0	0	0	0	0	(136)	0	0	0	(162)	0	0	0	(195)	0	0	0	(241)	0	0	0	(285)	0	0	0	(358)	0	0	0	(404)	0	0	0	(451)	0	0	0	(474)	0	0	0	(537)	0	0	0	(581)	0	0	0	(572)	0	0	0	(625)	0	0	0
Other Operating Expenses	(6)	(11)	(8)	(9)	(5)	(11)	(15)	(18)	(8)	(16)	(24)	(25)	(10)	(30)	(27)	(64)	(14)	(42)	(64)	(33)	(25)	(73)	(51)	(44)	(30)	(154)	(138)	(155)	32	3	(9)	47	25	153	168	197	102	122	199	212	109	267	219	223	176	169	193	204	166	125	138	132	209	230	189	161	169	109	68	84
Operating Income	570 N/A	580 +2%	583 +1%	601 +3%	525 -13%	571 +9%	605 +6%	612 +1%	681 +11%	697 +2%	710 +2%	757 +7%	805 +6%	842 +5%	897 +7%	938 +5%	980 +4%	1 046 +7%	1 151 +10%	1 210 +5%	1 296 +7%	1 357 +5%	1 460 +8%	1 538 +5%	1 670 +9%	1 770 +6%	1 942 +10%	1 998 +3%	2 098 +5%	2 228 +6%	2 222 0%	2 362 +6%	2 559 +8%	2 817 +10%	3 077 +9%	3 175 +3%	3 307 +4%	3 564 +8%	4 037 +13%	4 209 +4%	3 783 -10%	4 026 +6%	3 774 -6%	3 737 -1%	3 192 -15%	3 142 -2%	3 338 +6%	3 404 +2%	3 551 +4%	3 712 +5%	3 894 +5%	3 909 +0%	4 162 +6%	4 130 -1%	3 968 -4%	4 021 +1%	3 997 -1%	3 910 -2%	3 491 -11%	3 525 +1%
Pre-Tax Income
Interest Income Expense	(120)	(124)	(126)	(148)	(164)	(211)	(241)	(252)	(277)	(218)	(216)	(237)	(346)	(309)	(333)	(343)	(340)	(359)	(395)	(424)	(442)	(473)	(544)	(609)	(602)	(675)	(690)	(655)	(646)	(692)	(650)	(724)	(727)	(904)	(1 000)	(1 056)	(1 033)	(1 136)	(1 043)	(249)	332	569	1 788	911	400	(61)	(1 223)	(999)	(781)	(695)	(911)	(1 054)	(1 069)	(1 179)	(1 130)	(1 106)	(1 000)	996	1 124	1 194
Non-Reccuring Items	(5)	0	0	0	(11)	0	0	0	89	0	0	0	54	0	0	0	2	0	0	0	6	0	0	0	(22)	(4)	473	470	490	490	14	21	(3)	6	9	7	26	270	262	258	237	(2)	4	9	1	65	52	52	80	(12)	1	3	(71)	7	6	3	639	(662)	(665)	(674)
Gain/Loss on Disposition of Assets	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	2	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(3)	0	0	0	0	0	0	0	(2)	0	0	0	(2)	0	0	0
Total Other Income	32	32	35	37	139	141	148	162	59	88	84	77	92	94	93	99	110	76	79	86	94	99	103	83	60	64	41	31	(17)	(23)	(15)	(7)	2	(8)	0	(1)	17	(2)	(21)	(2)	(18)	0	(137)	(209)	(227)	(235)	(93)	(48)	(12)	(34)	(31)	(29)	(30)	(9)	(17)	(14)	4	7	24	6
Pre-Tax Income	478 N/A	489 +2%	493 +1%	491 0%	490 0%	501 +2%	511 +2%	521 +2%	552 +6%	566 +3%	578 +2%	597 +3%	607 +2%	627 +3%	657 +5%	694 +6%	753 +9%	762 +1%	835 +10%	872 +4%	956 +10%	985 +3%	1 020 +4%	1 013 -1%	1 106 +9%	1 154 +4%	1 765 +53%	1 843 +4%	1 925 +4%	2 003 +4%	1 571 -22%	1 652 +5%	1 831 +11%	1 912 +4%	2 087 +9%	2 126 +2%	2 317 +9%	2 695 +16%	3 234 +20%	4 215 +30%	4 334 +3%	4 594 +6%	5 431 +18%	4 450 -18%	3 363 -24%	2 911 -13%	2 074 -29%	2 408 +16%	2 838 +18%	2 971 +5%	2 952 -1%	2 829 -4%	2 991 +6%	2 949 -1%	2 828 -4%	2 904 +3%	3 637 +25%	4 251 +17%	3 974 -7%	4 051 +2%
Net Income
Tax Provision	(112)	(114)	(120)	(123)	(114)	(118)	(118)	(122)	(140)	(141)	(137)	(135)	(136)	(135)	(149)	(156)	(185)	(190)	(223)	(224)	(252)	(256)	(254)	(220)	(201)	(202)	(373)	(438)	(452)	(492)	(341)	(369)	(449)	(443)	(500)	(491)	(536)	(611)	(613)	(869)	(949)	(1 032)	(1 356)	(1 115)	(755)	(615)	(368)	(415)	(553)	(565)	(641)	(596)	(701)	(716)	(702)	(720)	(851)	(993)	(919)	(959)
Income from Continuing Operations	366	375	373	368	376	383	394	400	413	426	440	461	471	491	508	538	568	571	611	647	704	728	765	792	904	952	1 392	1 404	1 473	1 510	1 229	1 283	1 381	1 468	1 585	1 633	1 781	2 083	2 621	3 346	3 385	3 561	4 074	3 334	2 608	2 296	1 706	1 994	2 286	2 406	2 311	2 233	2 290	2 233	2 125	2 183	2 786	3 258	3 055	3 093
Income to Minority Interest	(7)	(7)	(5)	(5)	(1)	1	1	1	0	0	0	2	7	1	1	(5)	(8)	(5)	(9)	(7)	(9)	(10)	(11)	(16)	(28)	(32)	(33)	(30)	(27)	(28)	(39)	(20)	(41)	(21)	(38)	(46)	(55)	(108)	(380)	(498)	(310)	(304)	(86)	5	(160)	(156)	(160)	(212)	(201)	(212)	(153)	(63)	(116)	(83)	(87)	(137)	(279)	(319)	(309)	(306)
Net Income (Common)	360 N/A	369 +3%	369 N/A	364 -1%	374 +3%	384 +3%	395 +3%	402 +2%	413 +3%	427 +3%	442 +4%	464 +5%	478 +3%	493 +3%	509 +3%	533 +5%	561 +5%	567 +1%	603 +6%	641 +6%	695 +8%	717 +3%	754 +5%	719 -5%	820 +14%	839 +2%	1 252 +49%	1 299 +4%	1 339 +3%	1 399 +4%	1 132 -19%	1 230 +9%	1 121 -9%	1 227 +9%	1 328 +8%	1 368 +3%	1 564 +14%	1 837 +17%	2 020 +10%	2 737 +35%	2 963 +8%	3 111 +5%	3 861 +24%	3 075 -20%	2 436 -21%	2 118 -13%	1 574 -26%	1 818 +15%	2 073 +14%	2 185 +5%	2 179 0%	2 173 0%	2 174 +0%	2 168 0%	2 039 -6%	2 083 +2%	2 507 +20%	2 940 +17%	2 745 -7%	2 787 +2%
EPS (Diluted)	0.28 N/A	0.27 -4%	0.27 N/A	0.26 -4%	0.26 N/A	0.27 +4%	0.28 +4%	0.29 +4%	0.29 N/A	0.31 +7%	0.32 +3%	0.33 +3%	0.34 +3%	0.35 +3%	0.31 -11%	0.32 +3%	0.36 +12%	0.35 -3%	0.37 +6%	0.4 +8%	0.42 +5%	0.44 +5%	0.46 +5%	0.71 +54%	0.54 -24%	0.57 +6%	0.8 +40%	0.94 +17%	0.71 -24%	0.74 +4%	0.59 -20%	0.7 +19%	0.6 -14%	0.64 +7%	0.69 +8%	0.73 +6%	0.92 +26%	0.94 +2%	1.07 +14%	1.42 +33%	1.55 +9%	1.65 +6%	2.05 +24%	1.64 -20%	0.47 -71%	1.12 +138%	0.83 -26%	0.96 +16%	0.41 -57%	0.55 +34%	0.53 -4%	0.45 -15%	0.43 -4%	0.43 N/A	0.44 +2%	0.39 -11%	0.5 +28%	0.59 +18%	0.54 -8%	0.55 +2%

Income Statement Balance Sheet Cash Flow Statement

Jointown Pharmaceutical Group Co Ltd
SSE:600998

Income Statement

Earnings Waterfall
Jointown Pharmaceutical Group Co Ltd

Income Statement
Jointown Pharmaceutical Group Co Ltd

See Also

Company

Help

Tools

Stocks

Jointown Pharmaceutical Group Co Ltd SSE:600998

Income Statement

Earnings Waterfall Jointown Pharmaceutical Group Co Ltd

Income Statement Jointown Pharmaceutical Group Co Ltd

See Also

Company

Help

Tools

Stocks

Jointown Pharmaceutical Group Co Ltd
SSE:600998

Earnings Waterfall
Jointown Pharmaceutical Group Co Ltd

Income Statement
Jointown Pharmaceutical Group Co Ltd